Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 264

1.

Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.

Leval A, Herweijer E, Ploner A, Eloranta S, Fridman Simard J, Dillner J, Young C, Netterlid E, Sparén P, Arnheim-Dahlström L.

J Natl Cancer Inst. 2013 Apr 3;105(7):469-74. doi: 10.1093/jnci/djt032. Epub 2013 Mar 13.

PMID:
23486550
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.

Herweijer E, Leval A, Ploner A, Eloranta S, Simard JF, Dillner J, Netterlid E, Sparén P, Arnheim-Dahlström L.

JAMA. 2014 Feb 12;311(6):597-603. doi: 10.1001/jama.2014.95.

PMID:
24519299
[PubMed - indexed for MEDLINE]
3.

Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.

Leval A, Herweijer E, Arnheim-Dahlström L, Walum H, Frans E, Sparén P, Simard JF.

J Infect Dis. 2012 Sep 15;206(6):860-6. doi: 10.1093/infdis/jis405. Epub 2012 Jul 18.

PMID:
22815381
[PubMed - indexed for MEDLINE]
Free Article
4.

Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.

Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK.

Lancet Infect Dis. 2011 Jan;11(1):39-44. doi: 10.1016/S1473-3099(10)70225-5. Epub 2010 Nov 8.

PMID:
21067976
[PubMed - indexed for MEDLINE]
5.

Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark.

Blomberg M, Dehlendorff C, Munk C, Kjaer SK.

Clin Infect Dis. 2013 Oct;57(7):929-34. doi: 10.1093/cid/cit436. Epub 2013 Jun 26.

PMID:
23804192
[PubMed - indexed for MEDLINE]
Free Article
6.

Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis.

Van de Velde N, Boily MC, Drolet M, Franco EL, Mayrand MH, Kliewer EV, Coutlée F, Laprise JF, Malagón T, Brisson M.

J Natl Cancer Inst. 2012 Nov 21;104(22):1712-23. doi: 10.1093/jnci/djs395. Epub 2012 Oct 27.

PMID:
23104323
[PubMed - indexed for MEDLINE]
Free Article
7.

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.

Gertig DM, Brotherton JM, Budd AC, Drennan K, Chappell G, Saville AM.

BMC Med. 2013 Oct 22;11:227. doi: 10.1186/1741-7015-11-227.

PMID:
24148310
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Health and economic implications of HPV vaccination in the United States.

Kim JJ, Goldie SJ.

N Engl J Med. 2008 Aug 21;359(8):821-32. doi: 10.1056/NEJMsa0707052.

PMID:
18716299
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women.

McCormack PL, Joura EA.

Drugs. 2010 Dec 24;70(18):2449-74. doi: 10.2165/11204920-000000000-00000. Review.

PMID:
21142263
[PubMed - indexed for MEDLINE]
10.

Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.

McCormack PL, Joura EA.

BioDrugs. 2011 Oct 1;25(5):339-43. doi: 10.2165/11205060-000000000-00000. Review.

PMID:
21942919
[PubMed - indexed for MEDLINE]
11.

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.

PMID:
17380109
[PubMed - indexed for MEDLINE]
Free Article
12.

Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.

Marty R, Roze S, Bresse X, Largeron N, Smith-Palmer J.

BMC Cancer. 2013 Jan 8;13:10. doi: 10.1186/1471-2407-13-10.

PMID:
23298365
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.

Muñoz N, Manalastas R Jr, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, Taddeo FJ, Esser MT, Vuocolo S, Haupt RM, Barr E, Saah A.

Lancet. 2009 Jun 6;373(9679):1949-57. doi: 10.1016/S0140-6736(09)60691-7. Epub 2009 Jun 1.

PMID:
19493565
[PubMed - indexed for MEDLINE]
14.

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM.

J Natl Cancer Inst. 2010 Mar 3;102(5):325-39. doi: 10.1093/jnci/djp534. Epub 2010 Feb 5.

PMID:
20139221
[PubMed - indexed for MEDLINE]
Free Article
15.

Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.

Oliphant J, Perkins N.

N Z Med J. 2011 Jul 29;124(1339):51-8.

PMID:
21952330
[PubMed - indexed for MEDLINE]
16.

The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme.

Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK.

Sex Transm Infect. 2011 Dec;87(7):544-7. doi: 10.1136/sextrans-2011-050234. Epub 2011 Oct 4.

PMID:
21970896
[PubMed - indexed for MEDLINE]
17.

Cost-effectiveness of different human papillomavirus vaccines in Singapore.

Lee VJ, Tay SK, Teoh YL, Tok MY.

BMC Public Health. 2011 Mar 31;11:203. doi: 10.1186/1471-2458-11-203.

PMID:
21453537
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.

Gertig DM, Brotherton JM, Saville M.

Sex Health. 2011 Jun;8(2):171-8. doi: 10.1071/SH10001. Review.

PMID:
21592430
[PubMed - indexed for MEDLINE]
19.

Cost-effectiveness analysis of the bivalent and quadrivalent human papillomavirus vaccines from a societal perspective in Colombia.

Aponte-González J, Fajardo-Bernal L, Diaz J, Eslava-Schmalbach J, Gamboa O, Hay JW.

PLoS One. 2013 Nov 18;8(11):e80639. doi: 10.1371/journal.pone.0080639. eCollection 2013.

PMID:
24260441
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The incidence of genital warts in Australian women prior to the national vaccination program.

Brotherton JM, Heywood A, Heley S.

Sex Health. 2009 Sep;6(3):178-84. doi: 10.1071/SH08079.

PMID:
19653953
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk